Selling to Employers

Why Omada Health should buy Physera and other MSK M&A digital health predictions

5.16.20

5 min. Read

Livongo: 10 percent utilization uptick. $215M RWE acquisition.

4.10.20

6 min. Read

RCT shows no effect for AI coach. Livongo ups enrollment rate.

3.06.20

8 min. Read

Strip companies tried to kill Livongo. Sanofi DTx distro.

2.28.20

8 min. Read

Omada hits 275K cumulative users. More on Pear, Limbix, ATX.

9.19.19

5 min. Read

Livongo’s beyond diabetes revenue. Fitbit loses exec to CVS-Aetna

9.06.19

3 min. Read

Quick data scan on federal contracts. Rethinking platform strategies.

8.30.19

5 min. Read

Livongo clients mostly small commercial pilots? FDA easing.

7.02.19

6 min. Read

Omada’s strategy. Boehringer invests in myopia DTx.

6.27.19

6 min. Read

Omada User Growth. Apple Work Experience. European DTx.

5.16.19

4 min. Read